Summary.-The response of multicellular tumour spheroids of the EMT6 cell line to combinations of hyperthermia and Bleomycin (BLM) or Adriamycin (ADM) has been investigated. Using this model system, we have demonstrated enhanced BLM cytotoxicity at 43°C and also heat-induced drug tolerance to BLM at 43°C. ADM cytotoxicity was not significantly increased after 43°C x 1 h but after 6 h at 42°C greatly enhanced cell-killing was evident. These results are discussed in relation to our previous data for EMT6 cells growing either as monolayer cultures in vitro or as solid tumours in mice.
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MULTICELLULAR TUMOUR SPHEROIDS are a useful in vitro model system possessing many characteristics of in vivo tumours not present in monolayer cultures (Sutherland & Durand, 1976) . The response of spheroids derived from various tumourcell lines to hyperthermia has been described by several workers. V79 spheroids have been shown to be less sensitive to hyperthermia than single cells, thermoresistance increasing with spheroid size (Durand, 1975) . Differential heat-killing across the spheroid has been reported bv Sutherland (1975) , the central cells being nmore sensitive to hyperthermia. Also, hyperthermia has been shown to enhance radiation damage (Durand, 1975; LuckeHuihle & Dertinger, 1977) and to increase the cytotoxicity of misonidazole (Sridhar & Sutherland, 1977) Assay methods.
-After treatment the spheroids were removed from the flask and washed in fresh medium. Twelve representative spheroids were then selected from each treatment group and placed in individual wells on plastic multidishes, each containing 1 ml medium over 0-5 ml agar (0.75%) for regrowth studies. An eyepiece graticule was used to record 2 perpendicular diameters for each spheroid every 2 days, and these measurements were used to calculate the growth delay for each treatment group. The remaining spheroids from each group were washed with 5 ml 0.075% trypsin in a plastic universal container and then incubated at 37TC in an excess of trypsin for 15 min. The universals were then centrifuged at 1000 rev/min (170 g) for 5 min and the cell pellet was resuspended in 1-5 ml medium. The cell suspension was then assayed for surviving fraction as has been described by Twentyman (1980) .
Drugs.-The drugs used in these experiments were:
(1) Bleomycin (BLM, Lundbeck) obtained as a freeze-dried 15mg plug. This was dissolved in Hanks' Balanced Salt Solution (HBSS), diluted to 2-5 mg/ml and stored at -20°C in small aliquots. Each aliquot was thawed at 37°C and further diluted with HBSS before use.
(2) Adriamycin (ADM: doxorubicin HCI, Pharmitalia) obtained as 10 mg freeze-dried powder with lactose. This was dissolved in HBSS, diluted to 250 mug/ml and stored at -20°C. Before use, an aliquot was thawed at 37°C and further diluted with HBSS.
Analysis of results.-For a first analysis of the regrowth data, mean spheroid diameter for each treatment group was plotted against time after treatment. This enabled comparison between the regrowth curves of the different treatment groups within an experiment. However, for a more detailed analysis of the results, individual regrowth plots were used to calculate the time taken to reach 4 times the original spheroid volume (the endpoint used in these particular studies, as by this time the treated groups have essentially assumed the growth characteristics of control spheroids). The geometric mean times were then calculated for both groups and from these data the growth delay with its 95% confidence limits was obtained for the experimental group. In some groups a small number of spheroids failed to regrow to the endpoint volume during the course of the experiment (generally about 3 weeks) and these spheroids were omitted from the subsequent statistical analysis. Such spheroids were always found in groups given heat together with high-dose BLM, where the surviving fraction was reduced to around 0 5-2 0%. At the time of treatment the spheroids were around 250 ,um in diameter, with an outer rim of dividing cells surrounding an inner non-proliferating population of cells. It is known that such spheroids contain 2-5 x 103 clonogenic cells. Therefore, at a survival level of 1.0% there are only on average 20-50 viable cells per spheroid. So, depending on the location of the surviving cells, it is possible that some of the spheroids at the lower end of this survival range will not regrow in 20 days. Over the range of spheroid size used in these experiments (200-300 ,um in diameter) failure to regrow did not appear to be related to the original size of the spheroid. Fig. 1 shows cell-survival data for spheroids disaggregated immediately after exposure to BLM for 1 h at 37°C and 43TC.
RESIULTS
The cytotoxicity of BLM at 43°C can be seen to be significantly enhanced at all drug doses.
In Fig. 2 , mean spheroid diameter has been plotted against days after treatment for 4 different groups of spheroids. From these data it is possible to see that, whereas heat alone and BLM at 37°C only However, wvhen this treatment preceded 20 ug/ml BLM at 43°C x 1 h the growth delay was reduced to 3*2 (2.4-3 9) days. Fig. 5 shows cell-survival data for spheroids disaggregated immediately after exposure to ADM for 1 h at 37°C and 430(1. Although the surviving fractions for spheroids treated at 43°C appear to be lower at, all drug doses, this reduction is not significantly greater than that expected from the independent action of the heat and drug treatments. This lack of enhanced ADM killing after heating at 43°C x I h is also reflected in the growthdelay data for these experimentts, a typical example of which is shown in Fig. 6 . The Table summarizes the growth delay data from this experiment for 2 doses of ADAI. Similar trends were seen in replicate experiments.
Prolonged exposure at 420C' has been shown to significantly enhance ADM cytotoxicity, whether the response of the spheroids was assayed in terms of surviving fraction or growtlh delay. Growtihdelay data calculated from a typical set of results is shown in Fig. 7 , 1973; Yatvin, 1977) . Growth delay is also a useful endpoint for experiments in which the time of assay after treatment is important. With some drug treatments there is considerable repair of potentially lethal damage over the 24 h after treatment, and in such cases assay of surviving fraction immediately after treatment will lead to artificially low estimations of cell survival (Twentyman, 1980) . Such phenomena are avoided in the regrowth assay.
As in the regrowth of solid tumours In spite of these considerations, the conclusions drawn from these studies are the same whether the response to treatment was assayed in terms of cell survival (Morgan et al., 1979) . Here, we reported that preheating at temperatures of 39-41°C induced thermal tolerance and also tolerance to BLM at 430C while not affecting its cytotoxicity at 3700. However, a limited series of in vivo experiments in which the solid EMT6 tumour was heated by immersion in a circulating waterbath at 43°C showed no evidence of either increased BLM cytotoxicity or of BLM tolerance after preheating at 400C (Morgan & Bleehen, 1981) . These in vivo results however show some discrepancies with those from other laboratories. Hahn et al. (1975) reported the enhanced BLM cytotoxicity seen under in vitro conditions also to be present in their solid tumour system in vivo. We have no explanation for these differences at this time. However, the lack of enhanced BLM cytotoxicity in vivo may be related to non-uniformity of temperature throughout the tumour, which is a common problem associated with waterbath heating. We have previously demonstrated both a temperature gradient between tumour and waterbath and also a temperature difference of up to 06°C between central and peripheral regions for the same tumour (Bleehen et al., 1977) . These temperature differences will be particularly important in experiments combining hyperthermia with cytotoxic drugs which show temperature threshold effects. For both BLM and ADM there appears to be a temperature threshold of around 43°C before there is a major potentiation of drug cytotoxicity (Hahn et al., 1975; Hahn & Strande, 1976) .
In these spheroid studies we have shown a significant enhancement of BLM cytotoxicity after 43°C x 1 h. This is thought to be related to the hyperthermic inhibition of repair mechanisms, and Meyn et al. (1979) have shown that the repair of BLM-induced DNA strand breaks important to cell survival is prevented at 43°C. However, ADM-increased cell killing was only observed after heating for more than 4 h at 420C or 42-5CC. Exposure to 1 ,ug/ml ADM for up to 3 h at 43°C did not significantly enhance cytotoxicity. Heating beyond 3 h was not possible, as cell survival after heat alone reaches the limit of detectability of the assay after this time. Inhibition of repair mechanisms cannot explain heat-induced ADM sensitization, as there is no evidence of repair over the 24 h after treatment. Hahn et al. (1975) suggest that the sensitization to ADM which they see at 430C may be due to either changes in cell-membrane permeability leading to increased ADM uptake at 43°C or to inhibition of active drug exclusion. Sutherland et al. (1979) have reported that 600-1 O000,tn diameter EMT6 spheroids are markedly more resistant to ADM than monolayer cultures of the same cell line. They have shown in fluorescence studies that this resistance is related in part to the poor penetration of ADM into the inner regions of the spheroid. This factor may therefore be important in explaining the lack of enhanced ADM cytotoxicity reported here at short heating times. Changes in membrane permeability after prolonged heating may help to explain the increased cytotoxicity seen after 6 h at 42/42.5TC. At the present time, however, we are unable to make any meaningful estimations of drug penetration into spheroids at the ADM concentrations used in these studies. With EMT6 monolayer cultures we have shown a similar pattern of ADM cytotoxicity at 42TC. At 43TC, however, this system shows some evidence of enhanced cell killing after 1 tg/ml ADM for 3 h (unpublished data). These results suggest that a time/ temperature threshold effect may be involved in determining ADM cytotoxicity in this system. The spheroids used in these studies were all of a small size (200-300m diameter). Other workers have shown that as spheroids increase in diameter, they develop central necrosis, and the outer rim of actively dividing cells surrounds an inner shell of slowly or non-cycling cells. An 02 gradient develops across the spheroid and the necrotic centre may be surrounded by a region of radiobiologically hypoxic cells (Sutherland & Durand, 1973) . We are currently continuing these investigations to study the significance of these different cell populations in the response of the spheroids to hyperthermia and cytotoxic drugs.
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